LabCorp Acquires Covance Inc. for $6.1B In Cash And Stock Deal – ValueWalk Premium
Laboratory Corp

LabCorp Acquires Covance Inc. for $6.1B In Cash And Stock Deal

Laboratory Corp. of America Holdings (NYSE:LH) announced on November 3, 2014 that it has entered into a stock and cash agreement with Covance Inc. (NYSE:CVD) totaling up to about $6.1 Billion.  Laboratory Corp specializes in testing services such as patient monitoring, diagnosis, treatment, etc.  Covance focuses on lab testing and drug development for industries such as chemical, agrochemical and food.

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

0